Speaker: Jaime Flamenbaum
Senior Ethics Advisor – Canadian Institute of Health Research
ERDERA’s ethics and regulatory experts are launching a dedicated webinar series to unravel two of the most cross-cutting and challenging topics in rare disease research: Advanced Therapy Medicinal Products (ATMPs) and Artificial Intelligence applied to biomedical research.
Each episode will explore the rules and guidance that make research compliant with regulatory requirements and ethical provisions — supporting both responsible practice and smooth clinical translation. Over time, the series may expand to address broader ethical and regulatory questions emerging across the rare disease landscape.
About this first introductory webinar
Before diving into ATMPs and AI, this introductory episode lays the groundwork: what does ethics mean along the research continuum, and how does it touch every stage of knowledge creation and mobilisation?
The session will present a theoretical framework for situating ethics across research activities. This framework will then be brought to life through a relevant case study discussion, giving participants a concrete reference point for the episodes ahead.
What you will take away
- A clear map of ethics implications across the full research continuum
- Familiarity with a practical framework for identifying ethical considerations at each stage
- Insight into how ethical reflection connects to regulatory compliance and clinical translation
- A shared foundation for engaging with the ATMPs and AI episodes that follow
Who should attend
Researchers, clinicians, regulatory affairs professionals, ethicists, and anyone involved in or supporting rare disease research who wants to engage responsibly with ATMPs or AI in a biomedical context.